Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma (NHL)

Explore clinical trials studying Non-Hodgkin's Lymphoma (NHL). Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma (NHL) trial results

Completed

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

NCT02071888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
  • John Theruer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

NCT00614042

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations
  • For additional information regarding sites for this trial call 919-319-9374 Birmingham, Alabama, United States
  • For additional information regarding sites for this trial call 919-319-9374 Augusta, Georgia, United States
  • For additional information regarding sites for this trial call 919-319-9374 Boston, Massachusetts, United States
  • For additional information regarding sites for this trial call 919-319-9374 Las Vegas, Nevada, United States
View Trial Details
Completed

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

NCT01527838

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
  • Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT01108341

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Hematology Oncology, P.C. Stamford, Connecticut, United States
View all 39 locations
View Trial Details

Related conditions